View Clinical Trial (Medical Research Study)
Validation of a Multi-gene Test for Lung Cancer Risk
| City: |
|
Columbus |
| State: |
|
Ohio |
| Zip Code: |
|
43221 |
| Conditions: |
|
Lung Cancer |
| Purpose: |
|
The purpose of this study is to determine the validity of a multi-gene Lung Cancer Risk Test
(LCRT). In the process, the investigators will establish a bank of NBEC samples and
corresponding blood samples from individuals demographically at increased risk for lung
cancer.
|
| Study Summary: |
|
Because more than 160,000 individuals die of lung cancer/year in the United States alone, it
is important to use the best possible methods to determine whether increased surveillance of
individuals at highest risk for lung cancer will result in reduced lung cancer mortality.
The Lung Cancer Risk Test (LCRT) proposed for evaluation promises to accurately identify the
10-15% of the population that is most susceptible to lung cancer based on genetic
predisposition. More than 90 million individuals in the United States alone are
demographically at high risk for lung cancer and potential candidates for increased
surveillance.
|
| Criteria: |
|
Inclusion Criteria:
- 20 or more pack year smoking history
- clinical need for diagnostic bronchoscopy
Exclusion Criteria:
- Lung Cancer within 3 months after the date of enrollment
|
| NCT ID: |
|
NCT01130285 |
| Primary Contact: |
|
Principal Investigator
James Willey, MD
University of Toledo Health Science Campus
James Willey, MD
Phone: 419.383.3543
Email: james.willey2@utoledo.edu
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Columbus, Ohio 43221
United States
Janice Drake
Phone: 614-293-4978
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|